OAS1 protein levels were up-regulated in breast cancer, COAD, ovarian cancer, renal clear cell carcinoma, endometrial cancer, lung cancer, pancreatic cancer, HNSC and glioblastoma, but down-regulated in liver cancer (Figure 1C). This evidence concerns the gene OAS1 and glioblastoma.